Cargando…
Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
OBJECTIVE: Diabetic nephropathy is associated with dedifferentiation of podocytes, losing the specialized features required for efficient glomerular function and acquiring a number of profibrotic, proinflammatory, and proliferative features. These result from tight junction and cytoskeletal rearrang...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114395/ https://www.ncbi.nlm.nih.gov/pubmed/21521871 http://dx.doi.org/10.2337/db10-1110 |
_version_ | 1782206060903268352 |
---|---|
author | Herman-Edelstein, Michal Thomas, Merlin C. Thallas-Bonke, Vicki Saleem, Moin Cooper, Mark E. Kantharidis, Phillip |
author_facet | Herman-Edelstein, Michal Thomas, Merlin C. Thallas-Bonke, Vicki Saleem, Moin Cooper, Mark E. Kantharidis, Phillip |
author_sort | Herman-Edelstein, Michal |
collection | PubMed |
description | OBJECTIVE: Diabetic nephropathy is associated with dedifferentiation of podocytes, losing the specialized features required for efficient glomerular function and acquiring a number of profibrotic, proinflammatory, and proliferative features. These result from tight junction and cytoskeletal rearrangement, augmented proliferation, and apoptosis. RESEARCH DESIGN AND METHODS: Experiments were performed in conditionally immortalized human podocytes developed by transfection with the temperature-sensitive SV40-T gene. Cells were then cultured in the presence of transforming growth factor (TGF)-β1 or angiotensin II in the presence or absence of a selective inhibitor of the TGF-β type I receptor kinase, SB-431542. Gene and protein expression were then examined by real-time RT-PCR and immunofluorescence, and correlated with changes observed in vivo in experimental diabetes. RESULTS: Treatment of cells with TGF-β1 resulted in dynamic changes in their morphology, starting with retraction and shortening of foot processes and finishing with the formation of broad and complex tight junctions between adjacent podocytes. This dedifferentiation was also associated with dose- and time-dependent reduction in the expression of glomerular epithelial markers (nephrin, p-cadherin, zonnula occludens-1) and increased expression of mesenchymal markers (α−smooth muscle actin, vimentin, nestin), matrix components (fibronectin, collagen I, and collagen IV α3), cellular proliferation, and apoptosis. The induction of diabetes in mice was also associated with similar changes in morphology, protein expression, and proliferation in glomerular podocytes. CONCLUSIONS: In response to TGF-β and other TGF-dependent stimuli, mature podocytes undergo dedifferentiation that leads to effacement of foot processes, morphologic flattening, and increased formation of intercellular tight junctions. This simplification of their phenotype to a more embryonic form is also associated with reentry of mature podocytes into the cell cycle, which results in enhanced proliferation and apoptosis. These “pathoadaptive” changes are seen early in the diabetic glomerulus and ultimately contribute to albuminuria, glomerulosclerosis, and podocytopenia. |
format | Online Article Text |
id | pubmed-3114395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-31143952012-06-01 Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy Herman-Edelstein, Michal Thomas, Merlin C. Thallas-Bonke, Vicki Saleem, Moin Cooper, Mark E. Kantharidis, Phillip Diabetes Complications OBJECTIVE: Diabetic nephropathy is associated with dedifferentiation of podocytes, losing the specialized features required for efficient glomerular function and acquiring a number of profibrotic, proinflammatory, and proliferative features. These result from tight junction and cytoskeletal rearrangement, augmented proliferation, and apoptosis. RESEARCH DESIGN AND METHODS: Experiments were performed in conditionally immortalized human podocytes developed by transfection with the temperature-sensitive SV40-T gene. Cells were then cultured in the presence of transforming growth factor (TGF)-β1 or angiotensin II in the presence or absence of a selective inhibitor of the TGF-β type I receptor kinase, SB-431542. Gene and protein expression were then examined by real-time RT-PCR and immunofluorescence, and correlated with changes observed in vivo in experimental diabetes. RESULTS: Treatment of cells with TGF-β1 resulted in dynamic changes in their morphology, starting with retraction and shortening of foot processes and finishing with the formation of broad and complex tight junctions between adjacent podocytes. This dedifferentiation was also associated with dose- and time-dependent reduction in the expression of glomerular epithelial markers (nephrin, p-cadherin, zonnula occludens-1) and increased expression of mesenchymal markers (α−smooth muscle actin, vimentin, nestin), matrix components (fibronectin, collagen I, and collagen IV α3), cellular proliferation, and apoptosis. The induction of diabetes in mice was also associated with similar changes in morphology, protein expression, and proliferation in glomerular podocytes. CONCLUSIONS: In response to TGF-β and other TGF-dependent stimuli, mature podocytes undergo dedifferentiation that leads to effacement of foot processes, morphologic flattening, and increased formation of intercellular tight junctions. This simplification of their phenotype to a more embryonic form is also associated with reentry of mature podocytes into the cell cycle, which results in enhanced proliferation and apoptosis. These “pathoadaptive” changes are seen early in the diabetic glomerulus and ultimately contribute to albuminuria, glomerulosclerosis, and podocytopenia. American Diabetes Association 2011-06 2011-05-21 /pmc/articles/PMC3114395/ /pubmed/21521871 http://dx.doi.org/10.2337/db10-1110 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Complications Herman-Edelstein, Michal Thomas, Merlin C. Thallas-Bonke, Vicki Saleem, Moin Cooper, Mark E. Kantharidis, Phillip Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy |
title | Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy |
title_full | Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy |
title_fullStr | Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy |
title_full_unstemmed | Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy |
title_short | Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy |
title_sort | dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy |
topic | Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114395/ https://www.ncbi.nlm.nih.gov/pubmed/21521871 http://dx.doi.org/10.2337/db10-1110 |
work_keys_str_mv | AT hermanedelsteinmichal dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy AT thomasmerlinc dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy AT thallasbonkevicki dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy AT saleemmoin dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy AT coopermarke dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy AT kantharidisphillip dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy |